Severe Hypokalemia Associated With Piperacillin-Tazobactam Use. [PDF]
Kravcik A, Zelt J, Kravcik S.
europepmc +1 more source
Investigation of Carbapenemase Resistance Genes and Plasmid-Mediated Quinolone Resistance Genes in Ceftolozane/Tazobactam-Resistant <i>Enterobacterales</i> and <i>Pseudomonas aeruginosa</i> Isolates. [PDF]
Çınar C +6 more
europepmc +1 more source
Impact of inoculum effect on <i>in vitro</i> activity of intermittent and continuous piperacillin-tazobactam infusion against ESBL-producing <i>Escherichia coli</i> in a hollow-fiber infection model. [PDF]
Giry M +6 more
europepmc +1 more source
Comparison of Ceftolozane-Tazobactam and Ceftazidime-Avibactam in the Treatment of Multidrug-Resistant/Difficult-to-Treat Resistant Pseudomonas aeruginosa Infections: A Systematic Review and Meta-analysis. [PDF]
Gatti M, De Paola R, Giorgi B, Pea F.
europepmc +1 more source
Lower Leg Hematoma Requiring Intervention During Piperacillin/Tazobactam Therapy. [PDF]
Henkel L, Reuter S, Karlsfeld MJ.
europepmc +1 more source
Global epidemiology of carbapenem-resistant <i>Pseudomonas aeruginosa</i>. [PDF]
Gottesdiener LS, Satlin MJ.
europepmc +1 more source
<i>In vivo</i> efficacy of cefiderocol against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant <i>Pseudomonas aeruginosa</i> carrying the AmpC E219K substitution. [PDF]
Rodríguez-Coello A +14 more
europepmc +1 more source
Piperacillin-Tazobactam Strikes Again: A Neutropenic Mystery Unraveled
Piperacillin-tazobactam is a broad-spectrum antibiotic commonly used in inpatient settings, particularly for febrile neutropenia. While its known adverse effects are mainly gastrointestinal, rare hematologic effects have been reported.
Nasser, Zeinab +3 more
core
A Ten-Year Trend of Antimicrobial Resistance in <i>Pseudomonas aeruginosa</i> From United States Medical Centers: Results From the INFORM Surveillance Program (2015-2024). [PDF]
Sader HS +4 more
europepmc +1 more source
Introduction: Cefotaxime is the empiric antibiotic of choice for spontaneous bacterial peritonitis (SBP). However, rising gram-positive pathogen rates have prompted consideration of piperacillin-tazobactam as an alternative.
Ajit Khanal, Anil Kumar Mishra
doaj

